![Philip Beachy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Beachy
Corporate Officer/Principal at
National Academy of Sciences
Profile
Philip Beachy is the founder of Fate Therapeutics, Inc. founded in 2007.
He is currently a Member of the National Academy of Sciences since 2002.
Dr. Beachy's education includes undergraduate and doctorate degrees from Stanford University.
Dr. Beachy is also the founder of PellePharm, Inc.
Philip Beachy active positions
| Companies | Position | Start |
|---|---|---|
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | 01/01/2002 |
Former positions of Philip Beachy
| Companies | Position | End |
|---|---|---|
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Founder | - |
| FATE THERAPEUTICS, INC. | Founder | - |
Training of Philip Beachy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
100
+
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
PellePharm, Inc.
PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Philip Beachy
